- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| Di | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 23.09. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | 2 | ASX | ||
| 19.09. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 1 | ASX | ||
| VITA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 18.09. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 18.09. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 1 | ASX | ||
| 17.09. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 1 | ASX | ||
| 05.09. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 02.09. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 2 | ASX | ||
| 01.09. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 1 | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Half Year Presentation | - | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Dividend/Distribution - VLS | - | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Half Year Accounts | - | ASX | ||
| 26.06. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 24.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 23.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 22.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 18.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 17.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 7,000 | +0,43 % | Cannabis-Aktien: AKTIONÄR-Tipp Green Thumb dreht auf | Zum Wochenstart verzeichnet der Cannabis-Sektor eine Renencance. Zweistellige Kursgewinne sind dabei keine Seltenheit. Grund für den neuen Boom bei den Kiffer-Aktien: US-Präsident Donald Trump hat ein... ► Artikel lesen | |
| INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
| ALNYLAM PHARMACEUTICALS | 393,80 | -0,63 % | H.C. Wainwright bestätigt Kaufempfehlung für Alnylam: Neue FDA-Richtlinien als Kurstreiber | ||
| CASSAVA SCIENCES | 3,375 | +4,65 % | Cassava Sciences stock initiated with Buy rating at Lucid Capital Markets | ||
| NEKTAR THERAPEUTICS | 47,400 | +1,28 % | Nektar Therapeutics: Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025 | SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that it will present results from the ongoing REZOLVE-AD Phase... ► Artikel lesen | |
| ADASTRA | 0,101 | -17,21 % | Adastra Holdings Ltd.: Adastra Holdings Enters into Agreements to Sell Subsidiaries | Langley, British Columbia--(Newsfile Corp. - October 8, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has entered into agreements to sell all of the issued... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 1,666 | +1,59 % | Sellas Life Sciences files to sell 19.69M shares of common stock for holders | ||
| ACADIA PHARMACEUTICALS | 17,285 | +0,12 % | Mizuho maintains Neutral rating on Acadia Pharmaceuticals stock ahead of Q3 | ||
| CATALYST PHARMACEUTICALS | 17,990 | +2,54 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals | CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule Holdings amends, converts 8% debentures | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Announces Change of Auditor | Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| ZELIRA THERAPEUTICS | 0,184 | -2,65 % | ZELIRA THERAPEUTICS LIMITED: Appendix 4G | ||
| SOLIGENIX | 1,685 | 0,00 % | SOLIGENIX, INC.: Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte for the Treatment of Cutaneous T-Cell Lymphoma | FLASH 2 Study Interim Efficacy Analysis Targeted for 1H2026 Enrollment Update Remains on Track for 4Q2025 PRINCETON, N.J., Oct. 7, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq:... ► Artikel lesen | |
| OPUS GENETICS | 1,698 | +0,83 % | Opus Genetics, Inc.: Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5) | Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular serious adverse events or dose-limiting toxicitiesLasting, durable responses... ► Artikel lesen |
VITA LIFE SCIENCES LIMITED gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITA LIFE SCIENCES LIMITED finden Sie auf Wallstreet Online.